Women are 34% more likely to have severe side effects during and after cancer treatment than men.
Researchers have developed a tool that may help doctors figure out who has the highest risk of fatigue after breast cancer treatment.
A research letter estimates that modern radiation therapy techniques are less likely to cause heart problems than radiation therapy techniques used 20 or more years ago.
To provide practical approaches to managing cancer pain, the American Society of Clinical Oncology (ASCO) developed a special series of 14 articles on pain in people with cancer, including breast cancer.
A new study has found that exercise eases joint pain that's a common side effect of aromatase inhibitors.
A small study suggests that changes in brain activity may be the cause of chemo brain.
A study suggests Black women are about 3.5 times more likely to develop lymphedema than white women.
Mindfulness meditation and survivorship education classes eased symptoms of depression in younger women treated for breast cancer.
When long-term side effects such as fatigue or joint pain go untreated, they can lead to anxiety and depression among breast cancer survivors.
A small study has found that acupressure can help relieve long-term fatigue in women who've been treated for breast cancer.
A study suggests lifestyle changes aimed at getting to and maintaining a healthy weight as well as promoting the flow of lymph fluid can help reduce lymphedema risk in women who've been treated for breast cancer.
Electroacupuncture ‚Äì a type of acupuncture where a small electric current passes between pairs of acupuncture needles ‚Äì has been found to ease fatigue, anxiety, and depression in women diagnosed with early-stage breast cancer who are taking an aromatase inhibitor.
A small study suggests that heart medicines, such as beta blockers or ACE inhibitors, taken along with Herceptin can reduce the risk of serious heart damage in women diagnosed with early-stage, HER2-positive breast cancer.
The antidepressant duloxetine can ease joint pain in women diagnosed with early-stage, hormone-receptor-positive breast cancer who are taking an aromatase inhibitor.
Researchers urge women who have had breast cancer treatment to keep their heart health in mind as they build long-term health.
Hormonal therapy medicines used to reduce the risk of recurrence have different side effects.
Non-white women have more severe pain with advanced breast cancer than white women.
While most women having breast cancer surgery won't develop an infection, research shows that infections after breast surgery happen more often than expected.
A small study shows that women who took the aromatase inhibitor Arimidex (chemical name: anastrozole) for 2 years didn't have any more thinking and memory problems than women who took a placebo pill for 2 years.
Most women who have breast cancer surgery have some type of arm problem, even more than a year after surgery.
New research suggests a link between hormonal therapy side effects (hot flashes, night sweats, joint pain) and a reduced risk of breast cancer coming back.
A small study shows that other factors besides breast cancer treatment contribute to bone loss in post-menopausal women.
Being older and having lower cognitive reserve levels may increase the risk of cognitive problems during and after chemotherapy.
Lower quality of life during and after breast cancer treatment seems to be closely linked to two factors: menopausal symptoms and chemotherapy side effects.